Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2/3 1Phase 2 1

Status

Completed 5

Sponsor Class

OTHER 42NETWORK 5INDUSTRY 4NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 5

Conditions

Lymphoma 13Neuroblastoma 10Leukemia 9Central Nervous System Neoplasms 9Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Brain Neoplasms 8Hodgkin Disease 5Burkitt Lymphoma 5Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Large B-Cell, Diffuse 4Dendritic Cell Sarcoma, Interdigitating 4Medulloblastoma 3Leukemia, Biphenotypic, Acute 3Astrocytoma 3Wilms Tumor 2Testicular Neoplasms 2Teratoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Osteosarcoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Malignant mesenchymal tumor 2Leukemia, Myeloid, Acute 2Leukemia, Monocytic, Acute 2Kidney Neoplasms 2Cardiotoxicity 2Carcinoma, Renal Cell 2

Interventions

Doxorubicin 13Bleomycin 12Vinblastine 11Prednisone 11Vincristine 10Etoposide 10Cyclophosphamide 10Radiotherapy 9Filgrastim 9Dacarbazine 7Procarbazine 6Granulocyte Colony-Stimulating Factor 5Dexamethasone 5ABVD protocol 5Vinorelbine 4Peripheral Blood Stem Cell Transplantation 4Melphalan 4Gemcitabine 4Cytarabine 4Cisplatin 4Carmustine 4etoposide phosphate 3Mechlorethamine 3Ifosfamide 3indolepropanol phosphate 2Whole-Body Irradiation 2Positron Emission Tomography Computed Tomography 2Polymerase Chain Reaction 2Podophyllotoxin 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NETWORK × Hodgkin Disease × Granulocyte Colony-Stimulating Factor × Clear all
NCT01026220 2022-04-28

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma

Children's Oncology Group

Phase 3 Completed
166 enrolled 14 charts
Lymphoid

Hodgkin Disease

NCT00302003 2021-03-30

Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma

Children's Oncology Group

Phase 3 Completed
287 enrolled 12 charts
Lymphoid

Hodgkin Disease

NCT00025259 2017-04-12

Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease

Children's Oncology Group

Phase 3 Completed
1,734 enrolled 18 charts
Lymphoid

Hodgkin Disease

NCT00070187 2013-10-17

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Children's Oncology Group

Phase 2/3 Completed
24 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

NCT00070304 2013-07-26

Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma

Children's Oncology Group

Phase 2 Completed
33 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡